Patent ID: 7408063

Claim:
A compound of formula (I): or a pharmaceutically acceptable salt or N-oxide or stereochemically isomeric form thereof, wherein -A- is a bivalent radical of formula selected from the group consisting of —CH 2 —CH 2 —; —CH 2 —CH 2 —CH 2 — and —CH 2 —O—; >Y 1 —Y 2 —is >C═CR 5 — wherein R 5 is hydrogen or halo R 1 is selected from the group consisting of hydrogen or halo; R 2 is selected from the group consisting of hydrogen, halo, or cyano; R 3 is selected from the group consisting of hydrogen, N-imidazolyl, —O—R 6 , and —NHR 8 ; wherein R 6 is selected from the group consisting of hydrogen, C 1-6 alkyl and hydroxyC 1-6 alkyl; R 8 is selected from the group consisting of hydrogen and C 1-6 alkylcarbonyl; and R 4 is hydrogen or C 1-6 alkyl.